| Year |
Citation |
Score |
| 2022 |
Branigan GL, Torrandell-Haro G, Soto M, Gelmann EP, Vitali F, Rodgers KE, Brinton RD. Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. Cancer Medicine. PMID 35293700 DOI: 10.1002/cam4.4650 |
0.491 |
|
| 2021 |
Gelmann EP. The expanding role of hormones in cancer. Endocrine Oncology (Bristol, England). 1: E1-E2. PMID 37435183 DOI: 10.1530/EO-21-0001 |
0.317 |
|
| 2020 |
Bowen C, Shibata M, Zhang H, Bergren SK, Shen MM, Gelmann EP. CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss. Cancer Research. PMID 32943441 DOI: 10.1158/0008-5472.CAN-20-1742 |
0.466 |
|
| 2019 |
Bowen C, Ostrowski MC, Leone G, Gelmann EP. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression. Cancer Research. PMID 31213464 DOI: 10.1158/0008-5472.Can-18-4110 |
0.593 |
|
| 2019 |
Molina A, Christos P, Hackett A, Nordquist L, Gelmann E, Stein M, Sternberg C, Beltran H, Gracey L, Galletti G, Giannakakou P, Nanus DM, Tagawa ST. Abstract CT097: Phase I trial of apalutamide plus abiraterone acetate, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ct097 |
0.393 |
|
| 2018 |
Leighton X, Bera A, Eidelman O, Bubendorf L, Zellweger T, Banerjee J, Gelmann EP, Pollard HB, Srivastava M. Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression. Plos One. 13: e0205837. PMID 30321230 DOI: 10.1371/Journal.Pone.0205837 |
0.556 |
|
| 2018 |
Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, ... ... Gelmann E, et al. Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate. Journal of Global Oncology. 1-14. PMID 30260755 DOI: 10.1200/Jgo.18.00063 |
0.543 |
|
| 2016 |
Neugut AI, Gelmann EP. Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors. European Urology. 69: 795-6. PMID 26099904 DOI: 10.1016/J.Eururo.2015.06.004 |
0.344 |
|
| 2015 |
Zhang H, Zheng T, Chua CW, Shen M, Gelmann EP. Nkx3.1 controls the DNA repair response in the mouse prostate. The Prostate. PMID 26660523 DOI: 10.1002/Pros.23131 |
0.484 |
|
| 2015 |
Bowen C, Zheng T, Gelmann EP. NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage. Cancer Research. 75: 2686-98. PMID 25977336 DOI: 10.1158/0008-5472.Can-14-3387 |
0.487 |
|
| 2015 |
Song LN, Silva J, Koller A, Rosenthal A, Chen EI, Gelmann EP. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase. Molecular Cancer Research : McR. 13: 913-22. PMID 25777618 DOI: 10.1158/1541-7786.Mcr-14-0680 |
0.46 |
|
| 2013 |
Muhlbradt E, Ma J, Severi G, Ortner E, Hayes V, Hoang HN, Stampfer M, Giles G, Pollak M, Gelmann EP. Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer. Genes & Cancer. 4: 535-45. PMID 24386513 DOI: 10.1177/1947601913506009 |
0.672 |
|
| 2013 |
Bowen C, Ju JH, Lee JH, Paull TT, Gelmann EP. Functional activation of ATM by the prostate cancer suppressor NKX3.1. Cell Reports. 4: 516-29. PMID 23890999 DOI: 10.1016/J.Celrep.2013.06.039 |
0.423 |
|
| 2013 |
Song LN, Bowen C, Gelmann EP. Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I. The Biochemical Journal. 453: 125-36. PMID 23557481 DOI: 10.1042/Bj20130012 |
0.366 |
|
| 2013 |
Lim E, Gelmann EP. Renal Cell Cancer Treated with a Single-Edged Sword Cell Reports. 3: 275-276. PMID 23438368 DOI: 10.1016/J.Celrep.2013.02.001 |
0.356 |
|
| 2012 |
Ruiz C, Oeggerli M, Germann M, Gluderer S, Stocker H, Andreozzi M, Thalmann GN, Cecchini MG, Zellweger T, Stürm S, Koivisto PA, Helin HJ, Gelmann EP, Glass AG, Gasser TC, et al. High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. The Prostate. 72: 1678-87. PMID 22473923 DOI: 10.1002/Pros.22521 |
0.631 |
|
| 2011 |
Abate-Shen C, Meneses AA, Kinkade CW, Mitrofanova A, Lefebvre C, Chua CW, Castillo-Martin M, Gelmann E, Shen MM, Califano A. Abstract SY22-01: Interrogating gene expression programs from preclinical analyses of genetically engineered mouse models Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Sy22-01 |
0.573 |
|
| 2010 |
Bowen C, Gelmann EP. NKX3.1 activates cellular response to DNA damage. Cancer Research. 70: 3089-97. PMID 20395202 DOI: 10.1158/0008-5472.CAN-09-3138 |
0.339 |
|
| 2009 |
Ju JH, Maeng JS, Lee DY, Piszczek G, Gelmann EP, Gruschus JM. Interactions of the acidic domain and SRF interacting motifs with the NKX3.1 homeodomain. Biochemistry. 48: 10601-7. PMID 19780584 DOI: 10.1021/Bi9013374 |
0.312 |
|
| 2009 |
Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, ... ... Gelmann EP, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Annals of Family Medicine. 7: 212-22. PMID 19433838 DOI: 10.1370/Afm.942 |
0.324 |
|
| 2009 |
Gelmann EP, Henshall SM. Clinically relevant prognostic markers for prostate cancer: the search goes on. Annals of Internal Medicine. 150: 647-9. PMID 19414846 |
0.485 |
|
| 2009 |
Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, et al. Mortality results from a randomized prostate-cancer screening trial. The New England Journal of Medicine. 360: 1310-9. PMID 19297565 DOI: 10.1056/Nejmoa0810696 |
0.58 |
|
| 2009 |
Muhlbradt E, Asatiani E, Ortner E, Wang A, Gelmann EP. NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation. Cancer Research. 69: 2615-22. PMID 19258508 DOI: 10.1158/0008-5472.Can-08-3022 |
0.656 |
|
| 2008 |
Grubb RL, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, ... ... Gelmann EP, et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. Bju International. 102: 1524-30. PMID 19035857 DOI: 10.1111/J.1464-410X.2008.08214.X |
0.564 |
|
| 2008 |
Markowski MC, Bowen C, Gelmann EP. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Research. 68: 6896-901. PMID 18757402 DOI: 10.1158/0008-5472.Can-08-0578 |
0.716 |
|
| 2008 |
Abate-Shen C, Shen MM, Gelmann E. Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Differentiation; Research in Biological Diversity. 76: 717-27. PMID 18557759 DOI: 10.1111/J.1432-0436.2008.00292.X |
0.542 |
|
| 2008 |
Taplin ME, Manola J, Oh WK, Kantoff PW, Bubley GJ, Smith M, Barb D, Mantzoros C, Gelmann EP, Balk SP. A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones. Bju International. 101: 1084-9. PMID 18399827 DOI: 10.1111/J.1464-410X.2008.07509.X |
0.548 |
|
| 2008 |
Gelmann EP. Complexities of prostate-cancer risk. The New England Journal of Medicine. 358: 961-3. PMID 18199856 DOI: 10.1056/NEJMe0708703 |
0.489 |
|
| 2008 |
Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Research. 68: 236-48. PMID 18172316 DOI: 10.1158/0008-5472.Can-07-2972 |
0.584 |
|
| 2008 |
Liao Z, Tan S, Dagvadorj A, Shen F, Gu L, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. TRANSCRIPTION FACTOR STAT5 SYNERGIZES WITH ANDROGEN RECEPTOR IN PROSTATE CANCER CELLS Journal of Urology. 179: 186-186. DOI: 10.1016/S0022-5347(08)60540-6 |
0.508 |
|
| 2007 |
Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 962-8. PMID 17507623 DOI: 10.1158/1055-9965.Epi-06-0861 |
0.59 |
|
| 2007 |
Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, Dunning AM, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, ... ... Gelmann E, et al. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Research. 67: 2951-6. PMID 17409400 DOI: 10.1158/0008-5472.Can-06-3591 |
0.55 |
|
| 2007 |
Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, ... ... Gelmann EP, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nature Genetics. 39: 645-9. PMID 17401363 DOI: 10.1038/Ng2022 |
0.502 |
|
| 2007 |
Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P, Gelmann E, Schoen RE, Buys S, Hayes RB, Berg CD. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial American Journal of Epidemiology. 165: 874-881. PMID 17244633 DOI: 10.1093/Aje/Kwk075 |
0.4 |
|
| 2007 |
Bowen C, Stuart A, Ju JH, Tuan J, Blonder J, Conrads TP, Veenstra TD, Gelmann EP. NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity. Cancer Research. 67: 455-64. PMID 17234752 DOI: 10.1158/0008-5472.CAN-06-1591 |
0.384 |
|
| 2007 |
Pinsky PF, Crawford ED, Kramer BS, Andriole GL, Gelmann EP, Grubb R, Greenlee R, Gohagan JK. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. Bju International. 99: 775-9. PMID 17223921 DOI: 10.1111/J.1464-410X.2007.06708.X |
0.581 |
|
| 2006 |
True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, Beer TM, Gelmann E, Datta M, Mostaghel E, Knudsen B, Lange P, Vessella R, Lin D, Hood L, et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. 103: 10991-6. PMID 16829574 DOI: 10.1073/Pnas.0603678103 |
0.598 |
|
| 2006 |
Ju JH, Maeng JS, Zemedkun M, Ahronovitz N, Mack JW, Ferretti JA, Gelmann EP, Gruschus JM. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor. Journal of Molecular Biology. 360: 989-99. PMID 16814806 DOI: 10.1016/J.Jmb.2006.05.064 |
0.373 |
|
| 2006 |
Shand RL, Gelmann EP. Molecular biology of prostate-cancer pathogenesis. Current Opinion in Urology. 16: 123-31. PMID 16679847 DOI: 10.1097/01.Mou.0000193384.39351.64 |
0.569 |
|
| 2006 |
Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK. Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial. The Journal of Urology. 175: 1286-90; discussion . PMID 16515981 DOI: 10.1016/S0022-5347(05)00706-8 |
0.547 |
|
| 2006 |
Rodriguez Ortner E, Hayes RB, Weissfeld J, Gelmann EP. Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Urology. 67: 311-5. PMID 16442598 DOI: 10.1016/J.Urology.2005.08.021 |
0.515 |
|
| 2006 |
Zheng SL, Ju JH, Chang BL, Ortner E, Sun J, Isaacs SD, Sun J, Wiley KE, Liu W, Zemedkun M, Walsh PC, Ferretti J, Gruschus J, Isaacs WB, Gelmann EP, et al. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Research. 66: 69-77. PMID 16397218 DOI: 10.1158/0008-5472.Can-05-1550 |
0.611 |
|
| 2006 |
Hayes JH, Oh WK, Kantoff PW, Manola JB, Smith MR, Gelmann EP, Bubley G, Balk SP, Taplin M. Mifepristone (RU-486) in androgen independent prostate cancer Journal of Clinical Oncology. 24: 14508-14508. DOI: 10.1200/Jco.2006.24.18_Suppl.14508 |
0.481 |
|
| 2005 |
Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, Gelmann EP, Nevalainen MT. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5863-8. PMID 16115927 DOI: 10.1158/1078-0432.Ccr-05-0562 |
0.581 |
|
| 2005 |
Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4776-89. PMID 16034054 DOI: 10.1200/Jco.2005.05.081 |
0.324 |
|
| 2005 |
Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screening round of a randomized trial Journal of the National Cancer Institute. 97: 433-438. PMID 15770007 DOI: 10.1093/Jnci/Dji065 |
0.528 |
|
| 2005 |
Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Research. 65: 1164-73. PMID 15734999 DOI: 10.1158/0008-5472.Can-04-2688 |
0.528 |
|
| 2005 |
Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer (Amsterdam, Netherlands). 47: 9-15. PMID 15603850 DOI: 10.1016/J.Lungcan.2004.06.007 |
0.323 |
|
| 2004 |
Gelmann EP, Semmes OJ. Expression of genes and proteins specific for prostate cancer. The Journal of Urology. 172: S23-6; discussion S2. PMID 15535438 |
0.519 |
|
| 2004 |
Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, et al. Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. The Journal of Urology. 172: S3-5. PMID 15535434 DOI: 10.1097/01.ju.0000142276.19511.ac |
0.469 |
|
| 2004 |
Amin A, Halabi S, Gelmann EP, Stadler W, Vogelzang N, Small E. 9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901. Urologic Oncology. 22: 398-403. PMID 15464920 DOI: 10.1016/J.Urolonc.2004.05.002 |
0.526 |
|
| 2004 |
Taylor KL, Shelby R, Gelmann E, McGuire C. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Journal of the National Cancer Institute. 96: 1083-94. PMID 15265970 DOI: 10.1093/Jnci/Djh194 |
0.342 |
|
| 2004 |
Song LN, Coghlan M, Gelmann EP. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Molecular Endocrinology (Baltimore, Md.). 18: 70-85. PMID 14593076 DOI: 10.1210/Me.2003-0189 |
0.439 |
|
| 2004 |
Andriole GL, Pinsky PF, Levin DL, Gelmann EP, Crawford ED, Reding DJ, Prorok PC, Gohagan JF. 1791: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Biopsy Rates and Cancer Characteristics of Initial (To) Screen (II) Journal of Urology. 171: 473-473. DOI: 10.1016/s0022-5347(18)38983-3 |
0.378 |
|
| 2003 |
Gelmann EP. Searching for the gatekeeper oncogene of prostate cancer. Critical Reviews in Oncology/Hematology. 46: S11-20. PMID 12850523 DOI: 10.1016/S1040-8428(03)00060-X |
0.618 |
|
| 2003 |
Gelmann EP, Bowen C, Bubendorf L. Expression of NKX3.1 in normal and malignant tissues. The Prostate. 55: 111-7. PMID 12661036 DOI: 10.1002/Pros.10210 |
0.544 |
|
| 2003 |
Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L. Tissue microarray analysis reveals prognostic significance of syndecan-I expression in prostate cancer Prostate. 55: 20-29. PMID 12640657 DOI: 10.1002/Pros.10209 |
0.516 |
|
| 2002 |
Gelmann EP. Molecular biology of the androgen receptor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 3001-15. PMID 12089231 DOI: 10.1200/Jco.2002.10.018 |
0.549 |
|
| 2002 |
Gelmann EP, Steadman DJ, Ma J, Ahronovitz N, Voeller HJ, Swope S, Abbaszadegan M, Brown KM, Strand K, Hayes RB, Stampfer MJ. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. Cancer Research. 62: 2654-9. PMID 11980664 |
0.513 |
|
| 2002 |
Martin MB, Voeller HJ, Gelmann EP, Lu J, Stoica EG, Hebert EJ, Reiter R, Singh B, Danielsen M, Pentecost E, Stoica A. Role of cadmium in the regulation of AR gene expression and activity. Endocrinology. 143: 263-75. PMID 11751618 DOI: 10.1210/Endo.143.1.8581 |
0.478 |
|
| 2001 |
Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL. Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology. 58: 561-6. PMID 11597539 DOI: 10.1016/S0090-4295(01)01305-X |
0.497 |
|
| 2000 |
Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials. 21: 273S-309S. PMID 11189684 DOI: 10.1016/S0197-2456(00)00098-2 |
0.468 |
|
| 2000 |
Steadman DJ, Giuffrida D, Gelmann EP. DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1. Nucleic Acids Research. 28: 2389-95. PMID 10871372 DOI: 10.1093/Nar/28.12.2389 |
0.372 |
|
| 1999 |
Bowen C, Voeller HJ, Kikly K, Gelmann EP. Synthesis of procaspases-3 and -7 during apoptosis in prostate cancer cells. Cell Death and Differentiation. 6: 394-401. PMID 10381629 DOI: 10.1038/sj.cdd.4400502 |
0.311 |
|
| 1998 |
Stearns V, Gelmann EP. Does tamoxifen cause cancer in humans? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 779-92. PMID 9469370 DOI: 10.1200/Jco.1998.16.2.779 |
0.336 |
|
| 1997 |
He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer Genomics. 43: 69-77. PMID 9226374 DOI: 10.1006/geno.1997.4715 |
0.514 |
|
| 1997 |
Cardillo M, Berchem G, Tarkington MA, Krajewski S, Krajewski M, Reed JC, Tehan T, Ortega L, Lage J, Gelmann EP. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation. The Journal of Urology. 158: 212-6. PMID 9186362 DOI: 10.1097/00005392-199707000-00073 |
0.564 |
|
| 1997 |
Gumerlock PH, Chi SG, Shi XB, Voeller HJ, Jacobson JW, Gelmann EP, deVere White RW. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. Journal of the National Cancer Institute. 89: 66-71. PMID 8978408 DOI: 10.1093/Jnci/89.1.66 |
0.527 |
|
| 1997 |
Gelmann EP. Androgen receptor mutations in prostate cancer. Cancer Treatment and Research. 87: 285-302. PMID 8886458 DOI: 10.1007/978-1-4613-1267-3_12 |
0.469 |
|
| 1994 |
Voeller HJ, Sugars LY, Pretlow T, Gelmann EP. p53 oncogene mutations in human prostate cancer specimens. The Journal of Urology. 151: 492-5. PMID 7904314 DOI: 10.1016/S0022-5347(17)35000-0 |
0.389 |
|
| 1993 |
Carroll AG, Voeller HJ, Sugars L, Gelmann EP. p53 oncogene mutations in three human prostate cancer cell lines. The Prostate. 23: 123-34. PMID 8104329 DOI: 10.1002/pros.2990230206 |
0.354 |
|
| 1991 |
Voeller HJ, Wilding G, Gelmann EP. v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells. Molecular Endocrinology (Baltimore, Md.). 5: 209-16. PMID 2038342 DOI: 10.1210/Mend-5-2-209 |
0.505 |
|
| 1990 |
Wilding G, Gelmann EP, Freter CE. Phosphoinositide metabolism in human prostate cancer cells in vitro. The Prostate. 16: 15-27. PMID 2154736 DOI: 10.1002/Pros.2990160103 |
0.377 |
|
| 1989 |
Wilding G, Valverius E, Knabbe C, Gelmann EP. Role of transforming growth factor-alpha in human prostate cancer cell growth. The Prostate. 15: 1-12. PMID 2798227 DOI: 10.1002/Pros.2990150102 |
0.34 |
|
| 1989 |
Wilding G, Chen M, Gelmann EP. Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens. The Prostate. 14: 103-15. PMID 2710689 DOI: 10.1002/Pros.2990140204 |
0.44 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2003 |
Song LN, Herrell R, Byers S, Shah S, Wilson EM, Gelmann EP. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Molecular and Cellular Biology. 23: 1674-87. PMID 12588987 DOI: 10.1128/Mcb.23.5.1674-1687.2003 |
0.3 |
|
| 2002 |
Liu MC, Gelmann EP. P53 gene mutations: Case study of a clinical marker for solid tumors Seminars in Oncology. 29: 246-257. PMID 12063677 DOI: 10.1053/Sonc.2002.32900 |
0.288 |
|
| 2000 |
Kimura K, Gelmann EP. Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation. The Journal of Biological Chemistry. 275: 8610-7. PMID 10722700 DOI: 10.1074/Jbc.275.12.8610 |
0.282 |
|
| 1996 |
Gelmann EP. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog? Journal of the National Cancer Institute. 88: 224-6. PMID 8613997 DOI: 10.1093/Jnci/88.5.224 |
0.275 |
|
| 1989 |
Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Molecular and Cellular Endocrinology. 62: 79-87. PMID 2545487 DOI: 10.1016/0303-7207(89)90115-9 |
0.272 |
|
| 2003 |
Kimura K, Gelmann EP. Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation. Cell Death and Differentiation. 9: 972-80. PMID 12181748 DOI: 10.1038/sj.cdd.4401049 |
0.272 |
|
| 2010 |
Beildeck ME, Gelmann EP, Byers SW. Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway. Experimental Cell Research. 316: 1763-72. PMID 20138864 DOI: 10.1016/J.Yexcr.2010.02.001 |
0.267 |
|
| 1999 |
Levin DL, Gelmann EP, Andriole GL, Chia D, Crawford ED. Free And Total Psa In 7,183 Pilot Study Participants In The Plco Screening Trial The Journal of Urology. 207. DOI: 10.1097/00005392-199904010-00831 |
0.264 |
|
| 2009 |
Cetiner H, Kir G, Gelmann EP, Ozdemirli M. Primary vulvar Ewing sarcoma/primitive neuroectodermal tumor: a report of 2 cases and review of the literature. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 1131-6. PMID 19820381 DOI: 10.1111/Igc.0B013E3181Acae33 |
0.26 |
|
| 1992 |
Dawson NA, Wilding G, Weiss RB, McLeod DG, Linehan WM, Frank JA, Jacob JL, Gelmann EP. A pilot trial of chemohormonal therapy for metastatic prostate carcinoma. Cancer. 69: 213-8. PMID 1727665 DOI: 10.1002/1097-0142(19920101)69:1<213::Aid-Cncr2820690135>3.0.Co;2-V |
0.259 |
|
| 1992 |
Tarkington M, Sommers CL, Gelmann EP, Tefft MC, Lynch JH. The effect of pH on the in vitro colony forming ability of transitional cell carcinoma cells treated with various chemotherapeutic agents: Implications for in vivo therapy Journal of Urology. 147: 511-513. PMID 1732633 DOI: 10.1016/S0022-5347(17)37290-7 |
0.259 |
|
| 1986 |
Lippman ME, Dickson RB, Bates S, Knabbe C, Huff K, Swain S, McManaway M, Bronzert D, Kasid A, Gelmann EP. 8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Research and Treatment. 7: 59-70. PMID 3013348 DOI: 10.1007/BF01806790 |
0.253 |
|
| 1992 |
Gelmann EP, Thompson EW, Sommers CL. Invasive and metastatic properties of MCF-7 cells and ras(H)-transfected MCF-7 cell lines International Journal of Cancer. 50: 665-669. PMID 1537635 DOI: 10.1002/Ijc.2910500431 |
0.248 |
|
| 2005 |
Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD. Methods for etiologic and early marker investigations in the PLCO trial. Mutation Research. 592: 147-54. PMID 16054167 DOI: 10.1016/J.Mrfmmm.2005.06.013 |
0.235 |
|
| 1987 |
Lippman ME, Dickson RB, Gelmann EP, Rosen N, Knabbe C, Bates S, Bronzert D, Huff K, Kasid A. Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. Journal of Cellular Biochemistry. 35: 1-16. PMID 3312244 DOI: 10.1002/jcb.240350102 |
0.232 |
|
| 1986 |
Lippman ME, Dickson RB, Kasid A, Gelmann E, Davidson N, McManaway M, Huff K, Bronzert D, Bates S, Swain S. Autocrine and paracrine growth regulation of human breast cancer. Journal of Steroid Biochemistry. 24: 147-54. PMID 3486321 DOI: 10.1016/0022-4731(86)90044-0 |
0.229 |
|
| 1985 |
Kasid A, Lippman ME, Papageorge AG, Lowy DR, Gelmann EP. Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. Science (New York, N.Y.). 228: 725-8. PMID 4039465 DOI: 10.1126/science.4039465 |
0.226 |
|
| 2007 |
Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer (Amsterdam, Netherlands). 56: 125-34. PMID 17196298 DOI: 10.1016/J.Lungcan.2006.11.015 |
0.223 |
|
| 1988 |
Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Molecular Endocrinology (Baltimore, Md.). 1: 216-23. PMID 3502607 DOI: 10.1210/mend-1-3-216 |
0.221 |
|
| 1987 |
Dickson RB, Kasid A, Huff KK, Bates SE, Knabbe C, Bronzert D, Gelmann EP, Lippman ME. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proceedings of the National Academy of Sciences of the United States of America. 84: 837-41. PMID 2880347 DOI: 10.1073/pnas.84.3.837 |
0.214 |
|
| 2015 |
Gelmann EP, Sawyers CL, Rauscher FJ. Molecular oncology: Causes of cancer and targets for treatment Molecular Oncology: Causes of Cancer and Targets For Treatment. 1-961. DOI: 10.1017/CBO9781139046947 |
0.213 |
|
| 1997 |
Gelmann EP, Lack E. DNA testing to refute a diagnosis of cancer. The New England Journal of Medicine. 337: 1245-7. PMID 9340530 DOI: 10.1056/NEJM199710233371718 |
0.208 |
|
| 2002 |
Taylor KL, Shelby RA, Schwartz MD, Ackerman J, LaSalle VH, Gelmann EP, McGuire C. The impact of item order on ratings of cancer risk perception. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 654-9. PMID 12101113 |
0.208 |
|
| 1988 |
Lippman ME, Dickson RB, Gelmann EP, Rosen N, Knabbe C, Bates S, Bronzert D, Huff K, Kasid A. Growth regulatory peptide production by human breast carcinoma cells. Journal of Steroid Biochemistry. 30: 53-61. PMID 3290584 DOI: 10.1016/0022-4731(88)90076-3 |
0.206 |
|
| 2002 |
Bowen C, Birrer M, Gelmann EP. Retinoblastoma protein-mediated apoptosis after gamma-irradiation. The Journal of Biological Chemistry. 277: 44969-79. PMID 12297496 DOI: 10.1074/jbc.M202000200 |
0.197 |
|
| 2004 |
Zhang Y, Glass A, Bennett N, Oyama KA, Gehan E, Gelmann EP. Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization. Cancer. 100: 300-7. PMID 14716764 DOI: 10.1002/cncr.11886 |
0.189 |
|
| 1988 |
Freter CE, Lippman ME, Cheville A, Zinn S, Gelmann EP. Alterations in phosphoinositide metabolism associated with 17 beta-estradiol and growth factor treatment of MCF-7 breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 2: 159-66. PMID 2840572 DOI: 10.1210/mend-2-2-159 |
0.187 |
|
| 1987 |
Dickson RB, Rosen N, Gelmann EP, Lippman ME. Receptor- and signal transductionrelated proto-oncogenes in breast cancer Trends in Pharmacological Sciences. 8: 372-375. DOI: 10.1016/0165-6147(87)90094-0 |
0.184 |
|
| 1986 |
Kasid A, Knabbe C, Dickson R, Gelmann E, Lippman M. v-H-ras Oncogene transforms hormone dependent human breast cancer cell line into hormone independent tumorigenic cell line Journal of Steroid Biochemistry. 25: 127. DOI: 10.1016/0022-4731(86)90797-1 |
0.166 |
|
| 1994 |
Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Research and Treatment. 31: 325-35. PMID 7881109 DOI: 10.1007/BF00666165 |
0.164 |
|
| 1983 |
Wong-Staal F, Josephs S, Dalla-Favera R, Westin E, Gelmann E, Franchini G, Gallo RC. Cellular onc genes: their role as progenitors of viral onc genes and their expression in human cells Hamatologie Und Bluttransfusion. 28: 178-185. PMID 6305787 DOI: 10.1007/978-3-642-68761-7_38 |
0.139 |
|
| 2005 |
Song LN, Gelmann EP. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. The Journal of Biological Chemistry. 280: 37853-67. PMID 16141201 DOI: 10.1074/jbc.M503850200 |
0.136 |
|
| 1985 |
Frederick WR, Epstein JS, Gelmann EP, Rook AH, Armstrong GR, Djeu JY, Jackson L, Manischewitz JF, Enterline J, Jacob J. Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon. The Journal of Infectious Diseases. 152: 162-70. PMID 2989380 DOI: 10.1093/infdis/152.1.162 |
0.129 |
|
| 2008 |
Song LN, Gelmann EP. Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex. The Journal of Biological Chemistry. 283: 25988-99. PMID 18632669 DOI: 10.1074/jbc.M800325200 |
0.128 |
|
| 1983 |
Wong-Staal F, Hahn B, Manzari V, Colombini S, Franchini G, Gelmann EP, Gallo RC. A survey of human leukaemias for sequences of a human retrovirus. Nature. 302: 626-8. PMID 6835396 DOI: 10.1038/302626A0 |
0.123 |
|
| 1988 |
Zajac-Kaye M, Gelmann EP, Levens D. A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein. Science (New York, N.Y.). 240: 1776-80. PMID 2454510 DOI: 10.1126/science.2454510 |
0.119 |
|
| 1982 |
Westin EH, Wong-Staal F, Gelmann EP, Dalla-Favera R, Papas TS, Lautenberger JA, Eva A, Reddy EP, Tronick SR, Aaronson SA, Gallo RC. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America. 79: 2490-4. PMID 6283530 DOI: 10.1073/Pnas.79.8.2490 |
0.11 |
|
| 1983 |
Clarke MF, Gelmann EP, Reitz MS. Homology of human T-cell leukaemia virus envelope gene with class I HLA gene. Nature. 305: 60-2. PMID 6888550 DOI: 10.1038/305060a0 |
0.103 |
|
| 1981 |
Wong-Staal F, Dalla-Favera R, Franchini G, Gelmann EP, Gallo RC. Three distinct genes in human DNA related to the transforming genes of mammalian sarcoma retroviruses Science. 213: 226-228. PMID 6264598 DOI: 10.1126/Science.6264598 |
0.1 |
|
| 1983 |
Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, Leibowitch J, Popovic M. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science (New York, N.Y.). 220: 865-7. PMID 6601823 DOI: 10.1126/Science.6601823 |
0.1 |
|
| 1985 |
Kleinerman ES, Ceccorulli LM, Zwelling LA, Twilley T, Herberman RB, Jacob J, Gelmann EP. Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 3: 1005-12. PMID 3926955 DOI: 10.1200/Jco.1985.3.7.1005 |
0.1 |
|
| 1983 |
Dalla-Favera R, Westin E, Gelmann EP, Martinotti S, Bregni M, Wong-Staal F, Gallo RC. The human onc gene c-myc: structure, expression, and amplification in the human promyelocytic leukemia cell line HL-60 Hamatologie Und Bluttransfusion. 28: 247-254. PMID 6305794 |
0.099 |
|
| 1984 |
Longo DL, Gelmann EP, Cossman J, Young RA, Gallo RC, O'Brien SJ, Matis LA. Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia. Nature. 310: 505-6. PMID 6087161 DOI: 10.1038/310505A0 |
0.098 |
|
| 1985 |
Preble OT, Rook AH, Steis R, Silverman RH, Krause D, Quinnan GV, Masur H, Jacob J, Longo D, Gelmann EP. Interferon-induced 2’-5’ oligoadenylate synthetase during interferon-α therapy in homosexual men with kaposi's sarcoma: Marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome Journal of Infectious Diseases. 152: 457-465. PMID 2993441 DOI: 10.1093/infdis/152.3.457 |
0.096 |
|
| 1975 |
Declève A, Niwa O, Gelmann E, Kaplan HS. Kinetics of propagation of B-tropic murine leukemia virus on Fv-1b cell lines: requirement for multiple cycles of cell replication for transformation and viral antigen expression by RadLV. Virology. 63: 367-83. PMID 163525 DOI: 10.1016/0042-6822(75)90310-4 |
0.093 |
|
| 1975 |
Declève A, Niwa O, Gelmann E, Kaplan HS. Replication kinetics of N- and B-tropic murine leukemia viruses on permissive and nonpermissive cells in vitro. Virology. 65: 320-32. PMID 165616 DOI: 10.1016/0042-6822(75)90038-0 |
0.092 |
|
| 1985 |
Rook AH, Manischewitz JF, Frederick WR, Epstein JS, Jackson L, Gelmann E, Steis R, Masur H, Quinnan GV. Deficient, hla-restricted, cytomegalovirus-specific cytotoxic t cells and natural killer cells in patients with the acquired immunodeficiency syndrome Journal of Infectious Diseases. 152: 627-630. PMID 2993445 DOI: 10.1093/infdis/152.3.627 |
0.091 |
|
| 1991 |
Razzaque A, Peters SM, Gelmann EP, Sheridan MJ, Rosenthal LJ. Analysis of peripheral blood lymphocytes of AIDS and high-risk patients for human cytomegalovirus transforming DNA sequences Intervirology. 32: 10-18. PMID 1849876 DOI: 10.1159/000150180 |
0.088 |
|
| 1983 |
Gelmann EP, Popovic M, Blayney D, Masur H, Sidhu G, Stahl RE, Gallo RC. Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. Science (New York, N.Y.). 220: 862-5. PMID 6601822 DOI: 10.1126/Science.6601822 |
0.085 |
|
| 1985 |
Siegel JP, Djeu JY, Stocks NI, Masur H, Gelmann EP, Quinnan GV. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes Journal of Clinical Investigation. 75: 1957-1964. PMID 2989337 DOI: 10.1172/JCI111912 |
0.084 |
|
| 1984 |
Gelmann EP, Franchini G, Manzari V, Wong-Staal F, Gallo RC. Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo). Proceedings of the National Academy of Sciences of the United States of America. 81: 993-7. PMID 6322194 DOI: 10.1073/Pnas.81.4.993 |
0.083 |
|
| 1982 |
Gelmann EP, Petri E, Cetta A, Wong-Staal F. Deletions of specific regions of the simian sarcoma-associated virus genome are found in defective viruses and in the simian sarcoma virus. Journal of Virology. 41: 593-604. PMID 6281470 DOI: 10.1128/jvi.41.2.593-604.1982 |
0.083 |
|
| 1983 |
Manzari V, Wong-Staal F, Franchini G, Colombini S, Gelmann EP, Oroszlan S, Staal S, Gallo RC. Human T-cell leukemia-lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences. Proceedings of the National Academy of Sciences of the United States of America. 80: 1574-8. PMID 6300858 DOI: 10.1073/Pnas.80.6.1574 |
0.082 |
|
| 1984 |
Sodroski J, Trus M, Perkins D, Patarca R, Wong-Staal F, Gelmann E, Gallo R, Haseltine WA. Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus. Proceedings of the National Academy of Sciences of the United States of America. 81: 4617-21. PMID 6087335 DOI: 10.1073/Pnas.81.15.4617 |
0.081 |
|
| 1981 |
Weinstein RA, Golomb HM, Grumet G, Gelmann E, Schechter GP. Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer. 48: 380-3. PMID 7237406 DOI: 10.1002/1097-0142(19810715)48:2<380::AID-CNCR2820480226>3.0.CO;2-N |
0.079 |
|
| 1984 |
Gelmann EP, Burny A, Kettmann R. Characterization of cellular sequences flanking an integrated bovine leukemia virus genome. Journal of Virology. 52: 988-90. PMID 6092727 DOI: 10.1128/jvi.52.3.988-990.1984 |
0.076 |
|
| 1986 |
Pass HI, Potter D, Shelhammer J, Macher A, Ognibene FP, Longo DL, Gelmann E, Masur H, Roth JA. Indications for and diagnostic efficacy of open-lung biopsy in the patient with acquired immunodeficiency syndrome (AIDS). The Annals of Thoracic Surgery. 41: 307-12. PMID 3954503 DOI: 10.1016/S0003-4975(10)62776-2 |
0.072 |
|
| 1994 |
Colomer R, Lupu R, Bacus SS, Gelmann EP. erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification. British Journal of Cancer. 70: 819-25. PMID 7947086 DOI: 10.1038/bjc.1994.405 |
0.071 |
|
| 1982 |
Dalla-Favera R, Gelmann EP, Martinotti S, Franchini G, Papas TS, Gallo RC, Wong-Staal F. Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29) Proceedings of the National Academy of Sciences of the United States of America. 79: 6497-6501. PMID 6292905 DOI: 10.1073/Pnas.79.21.6497 |
0.071 |
|
| 1989 |
Zajac-Kaye M, Avigan M, Takimoto M, Pittaluga S, Quinn J, Gelmann E, Levens D. Multifactorial regulation of the human c-myc oncogene. Current Topics in Microbiology and Immunology. 141: 247-52. PMID 3215053 DOI: 10.1007/978-3-642-74006-0_33 |
0.07 |
|
| 1985 |
Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, Gelmann EP, Lane HC, Longfield R, Overturf G. Cryptococcosis in the acquired immunodeficiency syndrome. Annals of Internal Medicine. 103: 533-8. PMID 3898951 DOI: 10.7326/0003-4819-103-4-533 |
0.07 |
|
| 1976 |
Gelmann EP, Niwa O, Declève A, Kaplan HS. X-ray potentiation of MuLV infection in vitro. Virology. 69: 561-9. PMID 176786 DOI: 10.1016/0042-6822(76)90485-2 |
0.068 |
|
| 1984 |
Gelmann EP, Psallidopoulos MC, Papas TS, Dalla-Favera R. Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin mu locus in a Burkitt lymphoma. Nature. 306: 799-803. PMID 6419123 DOI: 10.1038/306799a0 |
0.066 |
|
| 1985 |
Lane HC, Masur H, Gelmann EP, Longo DL, Steis RG, Chused T, Whalen G, Edgar LC, Fauci AS. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. The American Journal of Medicine. 78: 417-22. PMID 3872068 DOI: 10.1016/0002-9343(85)90332-8 |
0.066 |
|
| 1982 |
Wong-Staal F, Dalla-Favera R, Gelmann EP, Manzari V, Szala S, Josephs SF, Gallo RC. The v-sis transforming gene of simian sarcoma virus is a new onc gene of primate origin. Nature. 294: 273-5. PMID 6272127 DOI: 10.1038/294273A0 |
0.066 |
|
| 1982 |
Gelmann EP, Trainor CD, Wong-Staal F, Reitz MS. Molecular cloning of circular unintegrated DNA of two types of SEATO strain of gibbon ape leukemia virus Journal of Virology. 44: 269-275. PMID 6292490 DOI: 10.1128/jvi.44.1.269-275.1982 |
0.065 |
|
| 1985 |
Papadopoulos NM, Lane HC, Costello R, Moutsopoulos HM, Masur H, Gelmann EP, Fauci AS. Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome Clinical Immunology and Immunopathology. 35: 43-46. PMID 3873303 DOI: 10.1016/0090-1229(85)90076-5 |
0.06 |
|
| 1972 |
Gelmann EP, Cronan JE. Mutant of Escherichia coli deficient in the synthesis of cis-vaccenic acid Journal of Bacteriology. 112: 381-387. PMID 4562402 DOI: 10.1128/Jb.112.1.381-387.1972 |
0.056 |
|
| 1984 |
Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, Macher AM. Hepatitis B virus infection in the acquired immunodeficiency syndrome Annals of Internal Medicine. 101: 795-797. PMID 6497194 DOI: 10.7326/0003-4819-101-6-795 |
0.055 |
|
| 1983 |
Gelmann EP, Clanton DJ, Jariwalla RJ, Rosenthal LJ. Characterization and location of myc homologous sequences in human cytomegalovirus DNA Proceedings of the National Academy of Sciences of the United States of America. 80: 5107-5111. PMID 6308672 |
0.053 |
|
| 1978 |
Gelmann EP, Declève A, Kaplan HS. Biological and biochemical differences among ecotropic C-type RNA viral isolates chemically induced from C57BL/KA mouse embryo cells in vitro. Virology. 85: 198-210. PMID 206003 DOI: 10.1016/0042-6822(78)90424-5 |
0.052 |
|
| 1986 |
Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Gelmann E, Lehrman SN, Blum RM, Barry DW. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet (London, England). 1: 575-80. PMID 2869302 DOI: 10.1016/S0140-6736(86)92808-4 |
0.052 |
|
| 1985 |
Gelmann EP, Preble OT, Steis R, Lane HC, Rook AH, Wesley M, Jacob J, Fauci A, Masur H, Longo D. Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters The American Journal of Medicine. 78: 737-741. PMID 3838854 DOI: 10.1016/0002-9343(85)90276-1 |
0.05 |
|
| 1983 |
Gelmann EP, Josephs SF, Wong-Staal F. Two strains of baboon endogenous virus demonstrate a high degree of genetic conservation. Gene. 21: 161-4. PMID 6301945 DOI: 10.1016/0378-1119(83)90157-9 |
0.05 |
|
| 1979 |
Weinstein RA, Gelmann E, Golomb HM. Disseminated atypical mycobacterial infection in hairy-cell leukaemia. Lancet (London, England). 2: 1052-3. PMID 82068 DOI: 10.1016/S0140-6736(78)92376-0 |
0.049 |
|
| 1984 |
Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations Annals of Internal Medicine. 100: 92-106. PMID 6318629 DOI: 10.7326/0003-4819-100-1-92 |
0.049 |
|
| 1983 |
Josephs SF, Dalla-Favera R, Gelmann EP, Gallo RC, Wong-Staal F. 5' viral and human cellular sequences corresponding to the transforming gene of simian sarcoma virus. Science (New York, N.Y.). 219: 503-5. PMID 6297002 DOI: 10.1126/Science.6297002 |
0.048 |
|
| 1985 |
Ognibene FP, Steis RG, Macher AM, Liotta L, Gelmann E, Pass HI, Lane HC, Fauci AS, Parrillo JE, Masur H. Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Annals of Internal Medicine. 102: 471-5. PMID 3977195 DOI: 10.7326/0003-4819-102-4-471 |
0.048 |
|
| 1982 |
Franchini G, Gelmann EP, Dalla-Favera R, Gallo RC, Wong-Staal F. Human gene (c-fes) related to the onc sequences of Snyder-Theilen feline sarcoma virus. Molecular and Cellular Biology. 2: 1014-9. PMID 6290870 DOI: 10.1128/Mcb.2.8.1014 |
0.045 |
|
| 1981 |
Gallo RC, Gelmann EP. In search of Hodgkin's disease virus. The New England Journal of Medicine. 304: 169-70. PMID 6255330 DOI: 10.1056/Nejm198101153040310 |
0.044 |
|
| 1988 |
Averbuch SD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Annals of Internal Medicine. 109: 267-73. PMID 3395037 DOI: 10.7326/0003-4819-109-4-267 |
0.042 |
|
| 1981 |
Dalla-Favera R, Gelmann EP, Gallo RC, Wong-Staal F. A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus. Nature. 292: 31-5. PMID 6268983 DOI: 10.1038/292031A0 |
0.041 |
|
| 1987 |
Watkins EB, Findlay P, Gelmann E, Lane HC, Zabell A. Enhanced mucosal reactions in aids patients receiving oropharyngeal irradiation International Journal of Radiation Oncology, Biology, Physics. 13: 1403-1408. PMID 3624048 DOI: 10.1016/0360-3016(87)90237-9 |
0.041 |
|
| 1985 |
Fauci AS, Masur H, Gelmann EP, Markham PD, Hahn BH, Lane HC. NIH conference. The acquired immunodeficiency syndrome: an update Annals of Internal Medicine. 102: 800-813. PMID 2986509 DOI: 10.7326/0003-4819-102-6-800 |
0.038 |
|
| 1984 |
Ognibene FP, Shelhamer J, Gill V, Macher AM, Loew D, Parker MM, Gelmann E, Fauci AS, Parrillo JE, Masur H. The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage American Review of Respiratory Disease. 129: 929-932. PMID 6610373 DOI: 10.1164/arrd.1984.129.6.929 |
0.037 |
|
| 1987 |
Gelmann EP, Longo D, Clifford Lane H, Fauci AS, Masur H, Wesley M, Preble OT, Jacob J, Steis R. Combination chemotherapy of disseminated kaposi's sarcoma in patients with the acquired immune deficiency syndrome The American Journal of Medicine. 82: 456-462. PMID 2435150 DOI: 10.1016/0002-9343(87)90445-1 |
0.037 |
|
| 1984 |
Preble OT, Rook AH, Quinnan GV, Vilcek J, Friedman RM, Steis R, Gelmann EP, Sonnabend JA. Role of interferon in AIDS. Annals of the New York Academy of Sciences. 437: 65-75. PMID 6100011 DOI: 10.1111/J.1749-6632.1984.Tb37123.X |
0.021 |
|
| 1975 |
Cronan JE, Gelmann EP. Physical properties of membrane lipids: biological relevance and regulation Bacteriological Reviews. 39: 232-256. PMID 1100043 DOI: 10.1128/Mmbr.39.3.232-256.1975 |
0.019 |
|
| 1982 |
Gelmann E. Chemotherapy for Lymphoma in a Patient With Common Variable Immunodeficiency Archives of Internal Medicine. 142: 90. DOI: 10.1001/Archinte.1982.00340140092017 |
0.016 |
|
| 2004 |
Gelmann E, Glass A. Author reply Cancer. 101: 209-210. DOI: 10.1002/cncr.20334 |
0.01 |
|
| 1991 |
Manni A, Roodman GD, Gelmann EP, Hausheer F. Book review Breast Cancer Research and Treatment. 19: 289-296. DOI: 10.1007/BF01961166 |
0.01 |
|
| 1986 |
Stein CA, Saville W, Yarchoan R, Broder S, Gelmann EP. Suramin and function of the adrenal cortex. Annals of Internal Medicine. 104: 286-7. PMID 3946973 DOI: 10.7326/0003-4819-104-2-286_2 |
0.01 |
|
| 1985 |
Smith PD, Macher AM, Bookman MA, Boccia RV, Steis RG, Gill V, Manischewitz J, Gelmann EP. Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome. Annals of Internal Medicine. 102: 207-9. PMID 3881075 DOI: 10.7326/0003-4819-102-2-207 |
0.01 |
|
| 1984 |
Boccia RV, Gelmann EP, Baker CC, Marti G, Longo DL. A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome Annals of Internal Medicine. 101: 716-717. PMID 6486607 DOI: 10.7326/0003-4819-101-5-716_2 |
0.01 |
|
| 1984 |
Pass HI, Potter DA, Macher AM, Reichert C, Shelhammer JH, Masur H, Ognibene F, Gelmann E, Clifford Lane H, Fauci A, Roth JA, Clark RE. Thoracic manifestations of the acquired immune deficiency syndrome The Journal of Thoracic and Cardiovascular Surgery. 88: 654-658. DOI: 10.1016/s0022-5223(19)35432-7 |
0.01 |
|
| 1975 |
Gelmann EP, Steward JP. Faculty and students as admissions interviewers Academic Medicine. 50: 626-8. DOI: 10.1097/00001888-197506000-00009 |
0.01 |
|
| Hide low-probability matches. |